Growth factors, such as the transforming growth factor beta (TGFβ), play an important role in promoting metastasis of prostate cancer, thus understanding how TGFβ could induce prostate cancer cell migration may enable us to develop targeted strategies for treatment of advanced metastatic prostate cancer. To more clearly define the mechanism(s) involved in prostate cancer cell migration, we undertook a series of studies utilizing non-malignant prostate epithelial cells RWPE1 and prostate cancer DU145 and PC3 cells. Our studies show that increased cell migration was observed in prostate cancer cells, which was mediated through epithelial-to-mesenchymal transition (EMT). Importantly, addition of 
Growth factors, such as the transforming growth factor beta (TGFβ), play an important role in promoting metastasis of prostate cancer, thus understanding how TGFβ could induce prostate cancer cell migration may enable us to develop targeted strategies for treatment of advanced metastatic prostate cancer. To more clearly define the mechanism(s) involved in prostate cancer cell migration, we undertook a series of studies utilizing non-malignant prostate epithelial cells RWPE1 and prostate cancer DU145 and PC3 cells. Our studies show that increased cell migration was observed in prostate cancer cells, which was mediated through epithelial-to-mesenchymal transition (EMT). Importantly, addition of Furthermore, resveratrol, which decreases prostate cancer cell migration, inhibited TRPM7 expression and function including TGFβ-induced cell migration and activation of TRPM7 function. Together, these results suggest that Mg 2+ influx via TRPM7 promotes cell migration by inducing EMT in prostate cancer cells and resveratrol negatively modulates TRPM7 function thereby inhibiting prostate cancer metastasis.
K E Y W O R D S
cell migration, EMT, magnesium, prostate cancer, TRPM7 and growth/proliferation of human carcinoma cells. 10, 11 We have previously shown that TRPM7 is associated with cell proliferation and survival of prostate cancer cells. 5, 12 Similarly, studies have also indicated that TRPM7 plays a key role in prostate cancer cells. [13] [14] [15] Other studies have shown that TRPM7 is partially associated with epidermal growth factor (EGF)-induced epithelial to mesenchymal transition (EMT) in breast cancer cells 16 ; however its role in EMT in prostate cancer is not well defined. EMT is a process characterized by repression of E-cadherin expression, production of the type-III intermediate filament protein vimentin, and increases in cell migration, invasion, and initiation of metastasis. It is well established that during EMT, cells transform from epithelial to mesenchymal phenotype that leads to the loss of cell-cell adhesion to promote metastatic potential.
Expression of EMT markers (manifested by reduced E-cadherin and induced N-cadherin and vimentin expression) is a feature of many cancer subtypes with poor clinical prognoses, and there is evidence that EMT mediates the carcinogenesis of prostate cancer cells. [17] [18] [19] Growth factors perform a vital role in the growth of normal, hyperplastic, and malignant prostatic epithelium. Several growth factors such as epidermal growth factor (EGF) family, the fibroblast growth factor (FGF) family, the insulin-like growth factor (IGF) family, the transforming growth factor-beta (TGFβ) family, and the vascular endothelial growth factor (VEGF) family have shown to play a critical role in prostate cancer development. 20 Interestingly, TGFβ is found in a variety of tissues and is important for angiogenesis, promotes extracellular matrix formation, and suppresses the immune response. 21 Since TGFβ promotes angiogenesis, it can bring nutrients and oxygen to tumor cells and also function as an immune suppressor thereby protecting cancer cells from the host immune system. ranging from −100 mV to +100 mV and 100 ms duration were delivered at 2s intervals after whole cell configuration was formed.
| Electrophysiology
Currents were recorded at 2 kHz and digitized at 5-8 kHz. pClamp 10.1 software was used for data acquisition and analysis. Basal leak currents were subtracted from the final currents and average currents are
shown. All experiments were carried out at room temperature.
| Membrane preparations and Western blot analyses
Cells were harvested and stored at −80°C. Crude lysates were prepared from RWPE1 and DU145 cells as described previously in Singh et al. 25 Protein concentrations were determined, using the 3 | RESULTS
| Magnesium levels via TRPM7 promotes EMT induced cell migration in prostate cancer cells
We first examined the ability of prostate cells to migrate by utilizing human non-malignant prostate epithelial cells RWPE1 and human metastatic prostate cancer DU145 or PC3 using the wound-healing assay for cellular migration. As shown in Figure 1A , control noncancerous RWPE1 cells showed only a modest increase in cell migration as compared with DU145 cells. Similar results were also observed using the metastatic prostate cancer PC3 cells, which also showed a significant increase in cell migration (cumulative data presented in supplemental Figure S2 ). Importantly, a key feature for prostate cancer metastasis is the initiation of EMT, thus we looked at various EMT markers. Epithelial non-cancerous cells, such as RWPE1, are shown to express high levels of E-cadherin, whereas mesenchymal cells, such as DU145 and PC3, express N-cadherin and vimentin. Ecadherin is required for the formation of stable adherens junctions and thus the maintenance of an epithelial phenotype, and its loss is | 755 currents was observed in these cells (Supplemental Figure S1A) .
Collectively, these results demonstrate that TRPM7 may play an important role in inducing EMT in prostate cancer cells.
| TGFβ induces TRPM7 expression and enhances EMT in prostate cancer cells
TGFβ is known to induce tumor cell invasion by activating EMT in metastatic cancer thereby enhancing invasiveness and metastasis.
29,42
Thus, we further evaluated the role of TRPM7 in TGFβ-induced EMT in prostate cancer cells using both transwell and wound healing assays.
Importantly, increase in migration of DU145 and PC3 cells were Figures S1B and S1C). Interestingly, the expression of TRPM7 also increased in a time dependent manner upon treatment with TGFβ, which mimicked increased expression of EMT marker vimentin ( Figure 2D , quantification provided in supplemental Figure S1D) .
Notably, cells treated with TGFβ showed a significant increase in TRPM7 currents without altering the current-voltage (I-V) relationship (at +100 mV, 22.14 ± 3.40 pA/pF in control, 31.06 ± 3.84 pA/pF in TGFβ). In contrast, addition of 50μM 2-APB to DU145 cells significantly abolished this TGFβ-mediated increase (at +100 mV,
8.09 ± 1.15 pA/pF) ( Figures 2E and 2F) . Overall, the data presented thus far strongly suggests a correlation between TRPM7 and TGFβ-mediated increase in EMT in prostate cancer cells.
| Loss of TRPM7 expression inhibits TGFβ induced increase in EMT
To date, specific pharmacological TRPM7 blockers are not available, 2-APB is a non-specific inhibitor that also inhibit other calcium channels, thus we used genetic methods to inhibit TRPM7 expression and directly explored the role of TRPM7 channel in EMT. DU145 cells transfected with control shRNA (mock) showed no change in TRPM7 expression. However, silencing of TRPM7 (using shTRPM7) resulted in a significant decrease in TRPM7 expression ( Figure 3A) . Importantly, decreased EMT markers vimentin and N-cadherin was also observed in TRPM7 silenced cells when compared with control mock transfected cells ( Figure 3A) . Furthermore, TRPM7 silenced cells treated with TGFβ failed to restore vimentin and N-cadherin expression when compared with mock treated cells ( Figure 3A) . Moreover, at a functional level, TGFβ showed an increase in TRPM7 currents, but Similar results were also observed with PC3 cells, where knockdown of TRPM7 significantly decreased cell migration (data not shown). These results indicate that loss of TRPM7 will reverse the EMT status and inhibit cell migration, which is consistent with a recently published report. 13 Taken together, these results, show that TRPM7 not only regulates EMT, but also modulates TGFβ-induced enhancement of EMT.
| RSV inhibits EMT via blocking TRPM7 channel activity in prostate cancer cells
Resveratrol (RSV), a natural polyphenol found in wide variety of plants and fruits, has been suggested to induce cell cycle arrest and activate apoptosis-mediated cell death in cancer cells. Importantly, the anticarcinogenic effect of RSV in prostate cancer has been well established and studies have noticed that RSV inhibits the proliferation of androgen dependent and independent prostate cancer cell lines along with inhibiting EMT. [43] [44] [45] [46] To assess whether TRPM7 channels are critically involved in RSV-mediated inhibition on EMT, analysis of cell migration was performed. In DU145 and PC3 cells, pretreatment with RSV led to an inhibition of cell migration as observed using wound healing assays when compared to untreated cells ( Figure 4A , quantification provided in supplemental Figures S2E and S2F ).
Moreover, transwell migration assays also showed that RSV treatment of DU145 cells resulted in a significant reduction in total number of cells migrated (268.00 ± 10.70 in control vs 123.90 ± 9.78 in RSV)
( Figure 4C ). Expression of EMT markers vimentin and N-cadherin was Importantly, in both DU145 and PC3 cells, TRPM7 expression levels were also noticeably downregulated by RSV treatment, which is correlated to the levels of EMT markers ( Figure 4B , quantification provided in supplemental Figure S1E ). Correspondingly, TRPM7
currents were also significantly inhibited by the addition of RSV (at +100 mV, 22.14 ± 3.40 pA/pF in control, 10.44 ± 2.42 pA/pF in RSV treated cells), (Figures 4D and 4E ), suggesting that RSV treatment inhibits TRPM7 expression and function that correspond to the decrease in EMT and decrease in the migration of prostate cancer cells.
| RSV inhibits EMT enhanced by TGFβ by inhibiting TRPM7
Evidence has shown that RSV suppresses cancer metastasis through inhibiting TGFβ induced EMT. [47] [48] [49] To further delineate the role for TRPM7 in modulating RSV-mediated inhibition of EMT, we assessed migration of DU145 and PC3 cells with and without TGFβ treatment.
Similar to the data presented in Figure 4 , pretreatment of cells with RSV significantly abolished TGFβ induced increase of EMT markers with a significant decrease in both vimentin and N-cadherin levels ( Figure 5A , quantification provided in supplemental Figure S1F ).
Importantly, similar effects were also observed in TRPM7 expression levels showing that RSV inhibits TGFβ-induced increases in TRPM7 expression ( Figure 5A ). Consistent with these results, TGFβ-induced increase in TRPM7 currents was also abolished by the addition of RSV without altering the channel properties (at +100 mV, 22.14 ± 3. could contribute to cell migration and EMT, inhibition of channel activity using 2-APB points towards TRPM7 as being the major channel. TRPM7 has been shown to be inhibited by the addition of 2-APB, whereas TRPM6 is shown to be stimulated by the addition of 2-APB. 2-APB has also been shown to inhibit SOCE currents, however under these conditions no SOCE currents were observed suggesting that the currents observed are again mainly through TRPM7 channels.
| DISCUSSION
In addition, genetic studies using silencing method further established shown to inhibit prostate cancer metastasis, however the exact mechanism or the ion channels involved have yet to be determined. ; however, increases in TRPM7 activity upon the addition of growth factors provides an important clue towards these mechanisms. 6, 55, 56 Low Mg 2+ availability also inhibits cell-cycle progression leading to a G0/G1 arrest through the up-regulation of p27, p21, and p16. 57 In addition, proliferating cells were shown to contain more Mg 2+ than resting ones, 58 again supporting the overall role of TRPM7 in cancer progression. Experimental evidence had also showed that TRPM7-mediated Mg 2+ influx could influence signaling along the (E) Cells were treated with TGFβ for 24 h before being trypsinized, re-suspended in serum free media with or without 50 μM RSV, and placed in transwell inserts for 6 h. Four random fields at 10× were counted from four separate experiments indicating total cells migrated ± SEM. * indicate significance (P < 0.05) entire PI3K (phosphoinositide 3-kinase)/Akt/mTOR protein translation cascade. [59] [60] [61] Importantly, proteins inhibiting PI3K pathway efficiently suppress EMT, [62] [63] [64] suggesting that this pathway is crucial for reprogramming of tumor cells. Furthermore, this also might be a fundamental pathway that transduces Mg 2+ availability into cell EMT behavior. Together, these findings clearly outline the activation of TRPM7 is essential for EMT. We further show that the effect of RSVmediated inhibition of EMT is via the decrease in TRPM7 channel activity. Furthermore, increases in these early signaling events that are regulated by TRPM7 and are important for EMT induction may offer a novel approach for the prevention of prostate cancer metastasis.
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